BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
34.24
+0.39 (1.15%)
Apr 17, 2025, 4:00 PM EDT - Market closed
BridgeBio Pharma Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$53.00
Upside
+54.79%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $49 → $53 | Strong Buy | Maintains | $49 → $53 | +54.79% | Apr 15, 2025 |
| Redburn Atlantic | Redburn Atlantic | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +46.03% | Mar 31, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $44 → $50 | Buy | Maintains | $44 → $50 | +46.03% | Mar 24, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $49 | Strong Buy | Maintains | $45 → $49 | +43.11% | Feb 21, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $95 | Buy | Reiterates | $95 | +177.45% | Feb 21, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $49 → $52 | Buy | Maintains | $49 → $52 | +51.87% | Feb 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $49 | Strong Buy | Reiterates | $49 | +43.11% | Feb 13, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $48 → $49 | Buy | Maintains | $48 → $49 | +43.11% | Feb 12, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $45 → $50 | Buy | Maintains | $45 → $50 | +46.03% | Dec 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $49 | Strong Buy | Reiterates | $49 | +43.11% | Dec 16, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $45 → $48 | Buy | Maintains | $45 → $48 | +40.19% | Nov 25, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $42 → $45 | Strong Buy | Maintains | $42 → $45 | +31.43% | Nov 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $43 → $49 | Strong Buy | Maintains | $43 → $49 | +43.11% | Nov 25, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $44 → $45 | Buy | Maintains | $44 → $45 | +31.43% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $43 | Strong Buy | Reiterates | $43 | +25.58% | Oct 25, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $47 → $46 | Buy | Maintains | $47 → $46 | +34.35% | Oct 17, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.